Microtubule/Tubulin inhibitor, MMAD, Purity ≥98%

Cat. No.: X24-08-YM240

Microtubule/Tubulin inhibitor, MMAD, Purity ≥98%

Synonym: 203849-91-6; Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10; (2S)-N-[(2S)-1-[[(3R,4S,5S)-3-Methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide

  • CAS Number: 203849-91-6
  • Compound CID: 10723894
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
MMAD is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
771.07
Molecular Formula
C41H66N6O6S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
MMAD is a cytoskeletal signaling inhibitor that plays a key role in disrupting microtubule dynamics and leading to cell cycle arrest and apoptosis.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.